7Baggers
 magic mushroom psilocybin market 12.50% cagr growth with optimi  openPR.com Thu, 18 Sep 2025 13:27:49 GMT
 Psychedelics are suddenly drawing interest from big drugmakers  statnews.com Thu, 11 Sep 2025 07:00:00 GMT
 published on: 2025-08-31 13:18:19  Newser Sun, 31 Aug 2025 18:18:19 GMT
 published on: 2025-08-31 12:17:53  Newser Sun, 31 Aug 2025 17:17:53 GMT
 published on: 2025-08-30 21:12:41  Newser Sun, 31 Aug 2025 02:12:41 GMT
 published on: 2025-08-29 20:30:52  Newser Sat, 30 Aug 2025 01:30:52 GMT
 published on: 2025-08-29 14:40:29  Newser Fri, 29 Aug 2025 19:40:29 GMT
 published on: 2025-08-29 01:40:20  Newser Fri, 29 Aug 2025 06:40:20 GMT
 published on: 2025-08-28 22:49:05  Newser Fri, 29 Aug 2025 03:49:05 GMT
 published on: 2025-08-28 14:27:54  Newser Thu, 28 Aug 2025 19:27:54 GMT
 psychedelic drug development shows promise, but market path remains steep  insights.citeline.com Thu, 28 Aug 2025 09:52:03 GMT

COMPASS Pathways plc
(NASDAQ:CMPS) 

CMPS stock logo

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited a...

Founded: 2016
CEO: George Goldsmith  
Sector: Other
Industry: Other

Share this website to your friends